Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 7, 2025 • 8:00 PM ET

Date/Time Source News Release
07/17/2024 07:25 AM EDT GlobeNewswire ASLAN Pharmaceuticals Announces it Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and is Commencing Steps to Place Itself Into Voluntary Liquidation
07/15/2024 07:30 AM EDT GlobeNewswire ASLAN Pharmaceuticals Announces Receipt of Nasdaq Delisting Determination; Has Determined Not to Appeal
05/21/2024 07:00 AM EDT GlobeNewswire ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the American Thoracic Society International Conference
05/09/2024 07:00 AM EDT GlobeNewswire ASLAN Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
05/07/2024 07:30 AM EDT GlobeNewswire ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event
05/02/2024 09:00 AM EDT GlobeNewswire ASLAN Pharmaceuticals Announces Expansion of its Collaboration With Zenyaku to Investigate the Biology Underlying Differential Effects of Eblasakimab Compared to Other Biologics
04/30/2024 07:00 AM EDT GlobeNewswire ASLAN Pharmaceuticals to Host KOL Panel Discussion on Treatment Options for Atopic Dermatitis Patients With an Inadequate Response to Dupilumab
04/24/2024 07:00 AM EDT GlobeNewswire ASLAN Pharmaceuticals Announces Late Breaking Abstract on Eblasakimab in COPD Accepted for Presentation at the American Thoracic Society International Conference
04/22/2024 08:45 AM EDT GlobeNewswire ASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients
04/12/2024 08:00 AM EDT GlobeNewswire ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Page

Additional News

As of June 7, 2025 • 8:00 PM ET

Date/Time Source News Release
08/09/2024 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Friday, August 9th, 2024
08/09/2024 05:34 AM EDT US Earnings Reports Expected earnings - ASLAN Pharmaceuticals Limited
07/17/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Wed, Jul 17, 2024 as of 4:00 pm ET
07/17/2024 10:12 AM EDT SeekingAlpha ASLAN stock tumbles 54% after board votes to liquidate
07/17/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Wed, Jul 17, 2024 as of 10.00 am ET
07/16/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Tue, Jul 16, 2024 as of 4:00 pm ET
07/15/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Mon, Jul 15, 2024 as of 4:00 pm ET
07/15/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Mon, Jul 15, 2024 as of 10.00 am ET
07/15/2024 08:04 AM EDT SeekingAlpha ASLAN Pharmaceuticals gets delisting notice from Nasdaq
07/03/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Wed, Jul 03, 2024 as of 10.00 am ET
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.